Knights K M, McLean C F, Tonkin A L, Miners J O
Department of Clinical Pharmacology, Flinders University of South Australia, Bedford Park.
Br J Clin Pharmacol. 1995 Aug;40(2):153-6. doi: 10.1111/j.1365-2125.1995.tb05769.x.
The effects of gender and oral contraceptive steroids on the pharmacokinetics of (R)-ibuprofen were studied in groups of healthy adult males, females and oral contraceptive steroid (OCS) using females. The values of AUC, CLpo, t1/2 and Vss, app did not differ significantly between the groups. Similarly, the percentage unbound of (R)-ibuprofen in pooled plasma from the three groups was not statistically different. Since chiral inversion is the major determinant of (R)-ibuprofen clearance in humans, it may be inferred from these data that gender and OCS have little or no effect on conversion of (R)-ibuprofen to the pharmacologically active S-enantiomer. Moreover, it is unlikely that hormonal factors influence the activity of the human hepatic long-chain fatty-acid:CoA ligase, the enzyme mediating the rate limiting step of (R)-ibuprofen inversion.
在健康成年男性、女性以及口服避孕药类固醇(OCS)使用者(女性)组中,研究了性别和口服避孕药类固醇对(R)-布洛芬药代动力学的影响。三组之间的AUC、CLpo、t1/2和Vss, app值无显著差异。同样,三组混合血浆中(R)-布洛芬的游离百分比在统计学上也无差异。由于手性转化是人体中(R)-布洛芬清除率的主要决定因素,从这些数据可以推断,性别和OCS对(R)-布洛芬转化为药理活性S-对映体的影响很小或没有影响。此外,激素因素不太可能影响人肝脏长链脂肪酸:辅酶A连接酶的活性,该酶介导(R)-布洛芬转化的限速步骤。